Week in review: New IOP-lowering drops, post-lockdown intravitreal injections, air pollution and glaucoma

This week in the news, the FDA approves a first-in-class treatment for lowering IOP, post-lockdown intravitreal injection challenges remain, and air pollution worsens the risk of acute glaucoma.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553